News & announcements
38 press releases · Page 1 of 4
October 5, 2026
Stemedix highlights non-opioid pain management, PRP, and regenerative treatment options for chronic pain and fibromyalgia, emphasizing personalized care based on individual symptoms and medical history.
Read full release →
September 30, 2026
Stemedix highlights emerging research into stem cell therapy for neuropathic pain and nerve repair, while addressing current evidence, potential applications, and research limitations.
Read full release →
September 23, 2026
Stemedix introduces new patient education resources to help individuals better understand regenerative pain management, treatment eligibility, and long-term outcomes through physician-guided evaluations and current clinical research.
Read full release →
September 15, 2026
Stemedix highlights how regenerative pain management uses personalized evaluations, medical history, and condition-specific treatment planning to help patients better understand chronic pain care and the evaluation process.
Read full release →
September 8, 2026
Stemedix has released new educational resources highlighting regenerative therapy options, patient evaluation, and research on safety for individuals living with autoimmune pain and chronic inflammatory conditions.
Read full release →
September 1, 2026
Stemedix expands patient education on regenerative therapy, highlighting physician-guided, non-surgical treatment options that may help eligible patients manage chronic joint pain and preserve joint function.
Read full release →
July 7, 2026
Stemedix releases new educational findings exploring how multiple neurotransmitters contribute to Parkinson’s disease symptoms beyond dopamine-related movement disorders.
Read full release →
June 26, 2026
Stemedix highlights research on regenerative therapy and Parkinson’s disease, focusing on how cellular communication, inflammation, and neurotransmitter loss may influence brain function and emerging regenerative medicine treatment…
Read full release →
June 12, 2026
Stemedix expands its structured medical record review process for Parkinson’s disease patients, focusing on coordinated documentation, physician-guided evaluation, and support for individuals exploring regenerative therapy for…
Read full release →
June 5, 2026
Stemedix released an educational report on Parkinson’s disease, focusing on dopamine function and ongoing research in regenerative medicine treatment and neurological evaluation processes based on patient medical records.
Read full release →
May 29, 2026
Stemedix released an educational review on Parkinson’s disease, detailing cellular changes, symptom progression, and research on regenerative therapy for Parkinson’s disease using physician-reviewed medical record evaluations.
Read full release →
May 22, 2026
Stemedix expands its structured care coordination for Parkinson’s patients, focusing on physician-led medical record review and individualized planning for regenerative therapy and regenerative medicine treatment in Saint Petersburg, FL.
Read full release →